Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

No definitive link between finasteride and male breast cancer, but further research is needed.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Finasteride effectively treats baldness but may cause sexual side effects.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Hair transplantation for men has improved, offering natural, lasting results, and may be enhanced by certain medications and future technologies.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.